In vitro study of the hemocompatibility of superparamagnetic contrast agent for magnetic resonance imaging
- 1 January 1994
- journal article
- Published by Elsevier in Clinical Materials
- Vol. 15 (4) , 293-301
- https://doi.org/10.1016/0267-6605(94)90061-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Liver-directed superparamagnetic iron oxide: Quantitation of T2 relaxation effectsMagnetic Resonance Imaging, 1993
- New artificial connective matrix-like structure: thrombogenicity and use as endothelial cell culture supportBiomaterials, 1992
- Iron oxide nanoparticles for use as an MRI contrast agent: Pharmacokinetics and metabolismMagnetic Resonance Imaging, 1991
- Methods for the evaluation of biocompatibility of soluble synthetic polymers which have potential for biomedical use: 1 ? Use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for evaluation ofin vitro cytotoxicityJournal of Materials Science: Materials in Medicine, 1990
- Magnetic Starch Microspheres, Efficacy and Elimination A New Organ-Specific Contrast Agent for Magnetic Resonance ImagingInvestigative Radiology, 1990
- Superparamagnetic iron oxide nanoparticles as a liver MRI contrast agent: Contribution of microencapsulation to improved biodistributionMagnetic Resonance Imaging, 1989
- Superparamagnetic iron oxide: pharmacokinetics and toxicityAmerican Journal of Roentgenology, 1989
- Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.Radiology, 1987
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Automated colorimetric assay for T cell cytotoxicityJournal of Immunological Methods, 1983